Christiane Hamacher becomes head of Asia Pacific, Roche Pharmaceuticals

1 November 2016
roche-big

Roche Pharmaceuticals Asia Pacific says that Dr Christiane Hamacher has assumed the role of head of Asia Pacific (APAC), joining Swiss pharma giant Roche’s (ROG: SIX) global leadership team. She succeeds Alexander Hardy who was appointed head of global product strategy based in Switzerland.

Dr Hamacher joined Roche in 2007 and was most recently general manager of Roche Pharmaceuticals’ Czech Republic business. She has established a strong track record in strategic management and human resources, and has undertaken global commercial and operational roles in the USA, Europe and Asia. Prior to joining Roche, Dr Hamacher spent 10 years at Schering AG where she held senior managerial positions in oncology, human resources and was general manager Philippines.

In her new role, Dr Hamacher will assume responsibility for the development and commercialisation of Roche Pharmaceuticals’ innovative portfolio of medicines across APAC. She will be based in Singapore, the Roche group’s regional headquarters, and will lead more than 6,000 employees in 22 countries across the region.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical